Amphastar Pharmaceuticals, Inc. (AMPH)
21.52
-0.08
(-0.37%)
USD |
NASDAQ |
Aug 24, 16:00
21.51
-0.01
(-0.05%)
After-Hours: 20:00
Amphastar Pharmaceuticals Price to Book Value : 1.192 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.192 |
| August 21, 2026 | 1.196 |
| August 20, 2026 | 1.200 |
| August 19, 2026 | 1.204 |
| August 18, 2026 | 1.182 |
| August 17, 2026 | 1.155 |
| August 14, 2026 | 1.158 |
| August 13, 2026 | 1.117 |
| August 12, 2026 | 1.106 |
| August 11, 2026 | 1.131 |
| August 10, 2026 | 1.124 |
| August 07, 2026 | 1.151 |
| August 06, 2026 | 1.097 |
| August 05, 2026 | 1.121 |
| August 04, 2026 | 1.102 |
| August 03, 2026 | 1.120 |
| July 31, 2026 | 1.104 |
| July 30, 2026 | 1.128 |
| July 29, 2026 | 1.140 |
| July 28, 2026 | 1.116 |
| July 27, 2026 | 1.062 |
| July 24, 2026 | 1.036 |
| July 23, 2026 | 1.045 |
| July 22, 2026 | 1.069 |
| July 21, 2026 | 1.085 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.087 |
| July 17, 2026 | 1.093 |
| July 16, 2026 | 1.100 |
| July 15, 2026 | 1.074 |
| July 14, 2026 | 1.041 |
| July 13, 2026 | 1.068 |
| July 10, 2026 | 1.036 |
| July 09, 2026 | 1.053 |
| July 08, 2026 | 1.045 |
| July 07, 2026 | 1.112 |
| July 06, 2026 | 1.086 |
| July 02, 2026 | 1.087 |
| July 01, 2026 | 1.113 |
| June 30, 2026 | 1.117 |
| June 29, 2026 | 1.195 |
| June 26, 2026 | 1.257 |
| June 25, 2026 | 1.214 |
| June 24, 2026 | 1.213 |
| June 23, 2026 | 1.127 |
| June 22, 2026 | 1.058 |
| June 18, 2026 | 1.086 |
| June 17, 2026 | 1.120 |
| June 16, 2026 | 1.152 |
| June 15, 2026 | 1.138 |
| June 12, 2026 | 1.160 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Supernus Pharmaceuticals, Inc. | 2.544 |
| Liquidia Corp. | 32.09 |
| ANI Pharmaceuticals, Inc. | 2.853 |
| Corcept Therapeutics, Inc. | 18.84 |
| Veru, Inc. | 1.556 |
Price to Book Value Related Metrics
| PE Ratio | 12.61 |
| PS Ratio | 1.367 |
| Price to Free Cash Flow | 6.528 |
| Price | 21.52 |
| Earnings Yield | 7.93% |
| Market Cap | 915.29M |
| Operating PE Ratio | 8.734 |
| Normalized PE Ratio | 14.24 |